Capital Research Global Investors
HAE icon

Capital Research Global Investors’s Haemonetics HAE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$85M Sell
1,139,043
-438,280
-28% -$32.7M 0.02% 301
2025
Q1
$100M Sell
1,577,323
-2,661,631
-63% -$169M 0.02% 287
2024
Q4
$331M Sell
4,238,954
-203,699
-5% -$15.9M 0.07% 171
2024
Q3
$357M Sell
4,442,653
-2,472,556
-36% -$199M 0.07% 156
2024
Q2
$572M Buy
6,915,209
+240,458
+4% +$19.9M 0.13% 135
2024
Q1
$570M Buy
6,674,751
+151,183
+2% +$12.9M 0.13% 138
2023
Q4
$558M Sell
6,523,568
-99,580
-2% -$8.52M 0.14% 145
2023
Q3
$593M Sell
6,623,148
-66,391
-1% -$5.95M 0.16% 125
2023
Q2
$570M Buy
6,689,539
+35,797
+0.5% +$3.05M 0.15% 133
2023
Q1
$551M Buy
6,653,742
+697,678
+12% +$57.7M 0.16% 130
2022
Q4
$468M Sell
5,956,064
-330,212
-5% -$26M 0.14% 140
2022
Q3
$465M Buy
6,286,276
+4,840
+0.1% +$358K 0.15% 136
2022
Q2
$409M Buy
6,281,436
+829,430
+15% +$54.1M 0.13% 147
2022
Q1
$345M Buy
5,452,006
+3,402,873
+166% +$215M 0.09% 184
2021
Q4
$109M Buy
2,049,133
+915,385
+81% +$48.6M 0.02% 312
2021
Q3
$80M Sell
1,133,748
-1,545,588
-58% -$109M 0.02% 328
2021
Q2
$179M Sell
2,679,336
-3,538,162
-57% -$236M 0.04% 257
2021
Q1
$690M Buy
6,217,498
+579,763
+10% +$64.4M 0.17% 132
2020
Q4
$669M Buy
5,637,735
+812,220
+17% +$96.5M 0.17% 130
2020
Q3
$421M Buy
4,825,515
+837,512
+21% +$73.1M 0.13% 155
2020
Q2
$357M Buy
3,988,003
+1,094,203
+38% +$98M 0.11% 154
2020
Q1
$288M Buy
2,893,800
+199,000
+7% +$19.8M 0.11% 151
2019
Q4
$310M Buy
2,694,800
+143,800
+6% +$16.5M 0.09% 178
2019
Q3
$322M Hold
2,551,000
0.11% 167
2019
Q2
$307M Buy
2,551,000
+1,138,850
+81% +$137M 0.1% 168
2019
Q1
$124M Hold
1,412,150
0.04% 245
2018
Q4
$141M Sell
1,412,150
-211,850
-13% -$21.2M 0.05% 231
2018
Q3
$186M Hold
1,624,000
0.05% 238
2018
Q2
$146M Buy
1,624,000
+400,000
+33% +$35.9M 0.04% 266
2018
Q1
$89.5M Buy
1,224,000
+870,541
+246% +$63.7M 0.03% 302
2017
Q4
$20.5M Buy
+353,459
New +$20.5M 0.01% 374